Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal–Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK)

Published 2011 View Full Article

Authors

Keywords

Journal

JOURNAL OF MEDICINAL CHEMISTRY

Volume 54, Issue 18, Pages 6342-6363

Publisher

American Chemical Society (ACS)

Online

2011-08-04

DOI

10.1021/jm2007613

Ask authors/readers for more resources

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

JOURNAL OF MEDICINAL CHEMISTRY

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Find the ideal target journal for your manuscript

Create your own webinar